Analysis of cost and factors related to the return of medication to the hospital pharmacy of a private hospital in the City of Belem

• Autor(a) principal: Sena, Maria Pantoja Moreira de
• Data de Publicação: 2021
• Outros Autores: Oliveira , Camila Martins, Sales, Clarisse Andrade, Souza, Marcos Felipe Rodrigues de, Melo, Renato Bruno Cavalcante de, Freitas, Crystyanne de Sousa, Mello, Amanda Gabryelle Nunes Cardoso, Sena, Luann Wendel Pereira de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/21645
• topic: Medicamentos; Análise de custo; Devolução.; Medicines; Cost analysis; Devolution.; Medicamentos; Análisis de costos; Devolución.

Objective: analysis of reasons and costs related to the return of medication, after distribution, to the hospital pharmacy. Methods: This is a quantitative retrospective study in which the costs of returns from patients admitted to clinical and surgical units were evaluated, using the computerized hospital management system SOUL MV®. Results: the reasons and costs involved in the return of these products in the years 2018, 2019 and 2020, respectively, are expressed. A total of R$2,870,733.19 was declared. It is observed that in 2018 when the collective SDM was used, the return cost was BRL 1,161,956.41, equivalent to 40.4% of the total cost. In 2019 and 2020, with the single dose individualized system, expenses were reduced to 31.9% and 27.6%, respectively. The drug deadline was the most predominant (57.1%), followed by material in disagreement (9.2%), prescription suspension (8.2%), unused material (7.2%), duplicity (6 .1%), patient and/or procedure refusal (2.4%), incorrect request (2.1%), death (1.2%), patient transfer (0.5%) and procedure suspended (0.2%). Conclusion: The results of the study demonstrate that the use of individualized unit dose SDM significantly reduced return costs and drug-related errors. This practice can bring savings to health services when the returned medications are in a condition suitable for reuse by another patient. However, reuse requires discussion and planning, as the safety and success of treatments depend on care during storage.